Skip to content. Skip to navigation
Sections
Personal tools
You are here: Home Events Pharmaceutical Advocacy & Lobbying Forum
Navigation
Log in


Forgot your password?
New user?
Site Search
 
Search only the current folder (and sub-folders)
 
Document Actions

Pharmaceutical Advocacy & Lobbying Forum

Pursue Optimal Outcomes on Key Federal & State Legislative Issues and Maintaining Compliance

Type Conference
Language English
Date May 22, 2006 to
May 23, 2006
Venue Arnold & Porter Conference Center
555 Twelfth Street
Washington,DC, DC 20004
US
Chemistry Specialties
  • other
Chemistry Techniques
  • other
Contact Feliz
Exl Pharma
555 Eighth Avenue
New York, NY 10018
US
212-400-6240
888-221-6750
fcasanova@exlpharma.com
Add event to calendar vCal (Windows, Linux)
iCal (Mac OS X)
by Feliz Casanova last modified 03-04-06 09:47 PM

Within the dynamic political environment surrounding health policy, it is becoming more important for pharmaceutical, biotech, medical device and healthcare companies to play a larger role in state and federal government legislation in order to have an impact on issues and policies that may effect their organizations. Pharmaceutical and healthcare lobbying efforts topped $123 million in 2004 with an average increase of 10% each year. Almost every major pharmaceutical and healthcare company in the US has been growing their government relations and public affairs teams as a result. With the amount of time, energy, money and resources devoted to this area, there is stronger need for these organizations to establish best practices, form effective partnerships and learn new tactics to have an impact on legislation that is impacting their products and the industry as a whole.

Speakers

Doug Pinkham President, Public Affairs Council, Bill Mclntyre Vice President, Public Affairs, Christopher Hansen Group Executive Officer, Ed Reno Nationa Director, State Govrnment Affair, Kristen Morris Vice President, Government Relations and Public Policy, Patroski Lawson Assistant Director, Government Affairs, Kath Means Senior Health Policy Advisor and Nick Ruggieri Vice President, Government Affairs.

Session titles

Pursue Optimal Outcomes on Key Federal & State Legislative Issues and Maintaining Compliance

Cost

Register by March 17th, 2006 to take Advantage of our Early-Bird Pricing: Conference and Workshop $1595 Register by May 5th, 2006 and Pricing is as follows: Conference and Workshop $1795 After May 5th, 2006 Standard Pricing is as Follows: Conference and Workshop $1995 The FDA/government employee rate is $595 and there is a 30% discount for academics. Please note that valid identification will be required at the conference registration desk.

More information about this event…

« May 2013 »
Su Mo Tu We Th Fr Sa
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31
Sponsors
Web Search
 

Powered by Plone CMS, the Open Source Content Management System

This site conforms to the following standards: